BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 33513134)

  • 1. Quantifying epidemiological drivers of gambiense human African Trypanosomiasis across the Democratic Republic of Congo.
    Crump RE; Huang CI; Knock ES; Spencer SEF; Brown PE; Mwamba Miaka E; Shampa C; Keeling MJ; Rock KS
    PLoS Comput Biol; 2021 Jan; 17(1):e1008532. PubMed ID: 33513134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human African trypanosomiasis in the Democratic Republic of the Congo: disease distribution and risk.
    Lumbala C; Simarro PP; Cecchi G; Paone M; Franco JR; Kande Betu Ku Mesu V; Makabuza J; Diarra A; Chansy S; Priotto G; Mattioli RC; Jannin JG
    Int J Health Geogr; 2015 Jun; 14():20. PubMed ID: 26047813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicting the impact of COVID-19 interruptions on transmission of gambiense human African trypanosomiasis in two health zones of the Democratic Republic of Congo.
    Aliee M; Castaño S; Davis CN; Patel S; Miaka EM; Spencer SEF; Keeling MJ; Chitnis N; Rock KS
    Trans R Soc Trop Med Hyg; 2021 Mar; 115(3):245-252. PubMed ID: 33611586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A modelling assessment of short- and medium-term risks of programme interruptions for gambiense human African trypanosomiasis in the DRC.
    Huang CI; Crump RE; Crowley EH; Hope A; Bessell PR; Shampa C; Mwamba Miaka E; Rock KS
    PLoS Negl Trop Dis; 2023 Apr; 17(4):e0011299. PubMed ID: 37115809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modelling
    Davis CN; Keeling MJ; Rock KS
    J R Soc Interface; 2021 Oct; 18(183):20210419. PubMed ID: 34610258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identifying regions for enhanced control of gambiense sleeping sickness in the Democratic Republic of Congo.
    Huang CI; Crump RE; Brown PE; Spencer SEF; Miaka EM; Shampa C; Keeling MJ; Rock KS
    Nat Commun; 2022 Mar; 13(1):1448. PubMed ID: 35304479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modelling to infer the role of animals in gambiense human African trypanosomiasis transmission and elimination in the DRC.
    Crump RE; Huang CI; Spencer SEF; Brown PE; Shampa C; Mwamba Miaka E; Rock KS
    PLoS Negl Trop Dis; 2022 Jul; 16(7):e0010599. PubMed ID: 35816487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and implementation of a strategy for intensified screening for gambiense human African trypanosomiasis in Kongo Central province, DRC.
    Lumbala C; Kayembe S; Makabuza J; Lutumba P; Van Geertruyden JP; Bessell PR; Ndung'u JM
    PLoS Negl Trop Dis; 2020 Oct; 14(10):e0008779. PubMed ID: 33057341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modelling to Quantify the Likelihood that Local Elimination of Transmission has Occurred Using Routine Gambiense Human African Trypanosomiasis Surveillance Data.
    Davis CN; Castaño MS; Aliee M; Patel S; Miaka EM; Keeling MJ; Spencer SEF; Chitnis N; Rock KS
    Clin Infect Dis; 2021 Jun; 72(Suppl 3):S146-S151. PubMed ID: 33905480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening Strategies for a Sustainable Endpoint for Gambiense Sleeping Sickness.
    Castaño MS; Aliee M; Mwamba Miaka E; Keeling MJ; Chitnis N; Rock KS
    J Infect Dis; 2020 Jun; 221(Suppl 5):S539-S545. PubMed ID: 31876949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of stochastic and deterministic models for gambiense sleeping sickness at different spatial scales: A health area analysis in the DRC.
    Davis CN; Crump RE; Sutherland SA; Spencer SEF; Corbella A; Chansy S; Lebuki J; Miaka EM; Rock KS
    PLoS Comput Biol; 2024 Apr; 20(4):e1011993. PubMed ID: 38557869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness modelling to optimise active screening strategy for gambiense human African trypanosomiasis in endemic areas of the Democratic Republic of Congo.
    Davis CN; Rock KS; Antillón M; Miaka EM; Keeling MJ
    BMC Med; 2021 Apr; 19(1):86. PubMed ID: 33794881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human African trypanosomiasis transmission, Kinshasa, Democratic Republic of Congo.
    Simo G; Mansinsa Diabakana P; Kande Betu Ku Mesu V; Manzambi EZ; Ollivier G; Asonganyi T; Cuny G; Grébaut P
    Emerg Infect Dis; 2006 Dec; 12(12):1968-70. PubMed ID: 17326955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Feasibility of a dried blood spot strategy for serological screening and surveillance to monitor elimination of Human African Trypanosomiasis in the Democratic Republic of the Congo.
    Inocencio da Luz R; Phanzu DM; Kiabanzawoko ON; Miaka E; Verlé P; De Weggheleire A; Büscher P; Hasker E; Boelaert M
    PLoS Negl Trop Dis; 2021 Jun; 15(6):e0009407. PubMed ID: 34115754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Village-scale persistence and elimination of gambiense human African trypanosomiasis.
    Davis CN; Rock KS; Mwamba Miaka E; Keeling MJ
    PLoS Negl Trop Dis; 2019 Oct; 13(10):e0007838. PubMed ID: 31658269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessing the impact of aggregating disease stage data in model predictions of human African trypanosomiasis transmission and control activities in Bandundu province (DRC).
    Castaño MS; Ndeffo-Mbah ML; Rock KS; Palmer C; Knock E; Mwamba Miaka E; Ndung'u JM; Torr S; Verlé P; Spencer SEF; Galvani A; Bever C; Keeling MJ; Chitnis N
    PLoS Negl Trop Dis; 2020 Jan; 14(1):e0007976. PubMed ID: 31961872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modelling the impact of fexinidazole use on human African trypanosomiasis (HAT) transmission in the Democratic Republic of the Congo.
    Das AM; Chitnis N; Burri C; Paris DH; Patel S; Spencer SEF; Miaka EM; Castaño MS
    PLoS Negl Trop Dis; 2021 Nov; 15(11):e0009992. PubMed ID: 34843475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness of sleeping sickness elimination campaigns in five settings of the Democratic Republic of Congo.
    Antillon M; Huang CI; Crump RE; Brown PE; Snijders R; Miaka EM; Keeling MJ; Rock KS; Tediosi F
    Nat Commun; 2022 Feb; 13(1):1051. PubMed ID: 35217656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Performance evaluation of a prototype rapid diagnostic test for combined detection of gambiense human African trypanosomiasis and malaria.
    Lumbala C; Matovu E; Sendagire H; Kazibwe AJN; Likwela JL; Muhindo Mavoko H; Kayembe S; Lutumba P; Biéler S; Van Geertruyden JP; Ndung'u JM
    PLoS Negl Trop Dis; 2020 Apr; 14(4):e0008168. PubMed ID: 32251426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Population genetics of Trypanosoma brucei gambiense in sleeping sickness patients with treatment failures in the focus of Mbuji-Mayi, Democratic Republic of the Congo.
    Pyana PP; Sere M; Kaboré J; De Meeûs T; MacLeod A; Bucheton B; Van Reet N; Büscher P; Belem AMG; Jamonneau V
    Infect Genet Evol; 2015 Mar; 30():128-133. PubMed ID: 25535944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.